Hideki Ohdan

Last Updated :2024/05/15

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), Professor
Web Site
E-mail
hohdanhiroshima-u.ac.jp
Other Contact Details
"1-2-3 KASUMI, MINAMI-KU, HIROSHIMA 734-8551", Japan
TEL : (+81)82-257-5220 FAX : (+81)82-257-5224
Self-introduction
Surgeon, Hepatobiliary pancreas surgery, transplant surgery, liver transplant, kidney transplant, pancreas transplant, small intestine transplant, NK therapy, COVID-19, IPS, bench to bed

Basic Information

Major Professional Backgrounds

  • 2003/04/01, 2003/09/30, Hiroshima University, Hospital, Research Associate
  • 2003/10/01, 2004/03/31, Hiroshima University, Hospital, Research Associate
  • 2004/04/01, 2007/03/31, Hiroshima University, Hospital, Research Associate
  • 2007/04/01, 2008/03/31, Hiroshima University, Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Associate Professor
  • 2008/04/01, 2012/03/31, Hiroshima University, Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Professor
  • 2012/04/01, 2019/03/31, Hiroshima University, Department of Gastroenterological and Transplant Surgery, Applied Life Sciences, Professor

Educational Backgrounds

  • Hiroshima University, Faculty of Medicine, Japan, 1982/04, 1988/03
  • Hiroshima University, Graduate School, Division of Medical Sciences, Programs for Surgery, Japan, 1993/04, 1997/03

Academic Degrees

  • Ph.D. , M.D., Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Dentistry
  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery
  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Research Keywords

  • gastroenterological Surgery
  • organ transplantation
  • immunology

Affiliated Academic Societies

  • Japanese Surgical Society
  • the Japan Soceity for Transplantation
  • The Japanese Society of Gastroenterological Surgery
  • Japanese Liver Transplantation Soceity
  • Japanese Society of Hepato-Biliary-Pancreatic Surgery
  • The Japan Society of Hepatology
  • The Japan Society for Organ Preservation and Biology
  • Japanese Soceity for Clinical Renal Transplantation
  • The Japanese Soceity of Gastroenterology
  • Japan Organ Transplant Network
  • Hiroshima Donor Bank
  • Japan Soceity of Computer Aided Surgery
  • The Transplantation Society

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2024, Undergraduate Education, Intensive, Practice for medical research
  3. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2024, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2024, Liberal Arts Education Program1, 1Term, Introductory Seminar for First-Year Students
  6. 2024, Graduate Education (Master's Program) , Second Semester, General Clinical Medicine and Dentistry
  7. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  8. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  9. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Gastroenterological and Transplant Surgery
  10. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Gastroenterological and Transplant Surgery
  11. 2024, Graduate Education (Doctoral Program) , 2Term, Trends of Genome Editing in Medical Science

Research Activities

Academic Papers

  1. Long-term quality of life of living liver donors: A Japanese nationwide survey, LIVER TRANSPLANTATION, 28(11), 1800-1803, 202211
  2. High-Output Stoma Leading to the Diagnosis of Antiphospholipid Syndrome, CASE REPORTS IN GASTROENTEROLOGY, 16(2), 418-424, 2022
  3. Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection, JOURNAL OF GASTROENTEROLOGY, 57(9), 676-683, 202209
  4. Acute portal hypertension using portal vein ligation abrogates TRAIL expression of liver-resident NK cells, HEPATOLOGY COMMUNICATIONS, 6(9), 2551-2564, 202209
  5. Downregulation of thrombomodulin contributes to ischemia-reperfusion injury in mice with steatotic liver, HEPATOLOGY RESEARCH, 52(9), 762-772, 202209
  6. Liver resection is associated with good outcomes for hepatocellular carcinoma patients beyond the Barcelona Clinic Liver Cancer criteria: A multicenter study with the Hiroshima Surgical study group of Clinical Oncology, SURGERY, 171(5), 1303-1310, 202205
  7. Metachronous colorectal liver metastasis that occurred 10 years after laparoscopic colectomy: a case report, SURGICAL CASE REPORTS, 8(1), 20220801
  8. Polymorphisms in CTLA-4 predict de novo donor specific antibody formation after kidney transplantation, HUMAN IMMUNOLOGY, 83(6), 494-498, 202206
  9. Allograft liver failure awaiting liver transplantation in Japan, JOURNAL OF GASTROENTEROLOGY, 57(7), 495-504, 202207
  10. Hepatic resection using intraoperative ultrasound and near-infrared imaging with indocyanine green fluorescence detects hepatic metastases from gastric cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 91, 202202
  11. Prediction of anastomotic leakage after left-sided colorectal cancer surgery: a pilot study utilizing quantitative near-infrared spectroscopy, SURGERY TODAY, 52(6), 971-977, 202206
  12. Successful robotic proximal gastrectomy with side overlap esophagogastrostomy following preoperative chemotherapy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 94, 202205
  13. No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 29(5), 570-584, 202205
  14. Long COVID occurrence in COVID-19 survivors, SCIENTIFIC REPORTS, 12(1), 20220411
  15. Clostridium butyricum affects nutrition and immunology by modulating gut microbiota, BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 41(2), 30-36, 2022
  16. Percutaneous transluminal angioplasty with carbon dioxide for peripheral arterial disease after kidney transplantation: a case report with literature review, RENAL REPLACEMENT THERAPY, 6(1), 20200506
  17. Rectal Arteriovenous Malformation Treated by Transcatheter Arterial Embolization, CASE REPORTS IN GASTROENTEROLOGY, 14(1), 7-14, 2020
  18. Successful Resection of Solitary Abdominal Wall Metastasis of Sarcomatous Intrahepatic Cholangiocarcinoma, CASE REPORTS IN GASTROENTEROLOGY, 13(1), 66-72, 2019
  19. The characteristics of residual pneumoperitoneum after laparoscopic colorectal surgery, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 15(2), 320-327, 202204
  20. Omnidirectional camera and head-mount display contribute to the safety of laparoscopic surgery, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 31(4), 540-547, 20220401
  21. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan, SCIENTIFIC REPORTS, 12(1), 20220214
  22. Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice, JOURNAL OF CLINICAL INVESTIGATION, 119(11), 3226-3235, 200911
  23. Single-incision laparoscopic surgery using the glove technique with improved maneuverability achieved through fulcrum creation via a simple ring technique, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 13(1), 131-133, 202001
  24. Validation of the Tokyo guideline 2018 treatment proposal for acute cholecystitis from a single-center retrospective analysis, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 14(1), 14-20, 202101
  25. A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma, HPB, 23(1), 134-143, 202101
  26. Analysis of Risk Factors Affecting Incidence of Osteoporosis and Fragility Fractures in Liver Transplant Recipients, ANNALS OF TRANSPLANTATION, 26, 20210205
  27. Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial, GASTRIC CANCER, 24(2), 467-476, 202103
  28. Longterm Outcome of Liver Transplantation for Congenital Extrahepatic Portosystemic Shunt, LIVER TRANSPLANTATION, 27(2), 236-247, 202102
  29. Clinical indicators for the incidence of postoperative ileus after elective surgery for colorectal cancer, BMC SURGERY, 21(1), 20210211
  30. KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer, CANCER SCIENCE, 112(3), 1196-1208, 202103
  31. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan, PLOS ONE, 16(2), 20210205
  32. Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer, EJSO, 47(3), 613-619, 202103
  33. Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA), PLOS ONE, 16(2), 20210205
  34. Laparoscopic anterior resection for rectal stenosis caused byALTAinjection for internal hemorrhoids: A case report, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 14(2), 271-274, 202104
  35. Long-term outcomes of laparoscopic surgery in elderly patients with colorectal cancer: A single institutional matched case-control study, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 14(2), 200-206, 202104
  36. TLR-MyD88 signaling blockades inhibit refractory B-1b cell immune responses to transplant-related glycan antigens, AMERICAN JOURNAL OF TRANSPLANTATION, 21(4), 1427-1439, 202104
  37. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 19(1), 20210405
  38. Appendicitis with submucosal fecalith mimicking a submucosal tumor: a case report, SURGICAL CASE REPORTS, 7(1), 20210427
  39. Risk Factors for Anastomotic Leakage after Colorectal Surgery with Double-staple Technique Anastomosis: Impact of the Agatston Score, JOURNAL OF THE ANUS RECTUM AND COLON, 5(2), 181-187, 2021
  40. Donor age (>= 45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study, TRANSPLANT INTERNATIONAL, 34(5), 916-929, 202105
  41. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer, JOURNAL OF RADIATION RESEARCH, 62(2), 300-308, 202103
  42. Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients, BMC NEPHROLOGY, 22(1), 20210615
  43. Tumor budding as a predictive marker for 5-fluorouracil response in adjuvant-treated stage III colorectal cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26(7), 1285-1292, 202107
  44. Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification, BMC CANCER, 21(1), 20210605
  45. Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy, MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 21, 171-179, 20210611
  46. Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers, BRITISH JOURNAL OF CANCER, 125(1), 65-77, 20210706
  47. Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients, MEDICINE, 100(26), 20210702
  48. Long-term survival by repeat resection for metastases from primary retroperitoneal leiomyosarcoma: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 82, 202105
  49. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib, INTERNAL MEDICINE, 60(13), 2047-2053, 2021
  50. KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancer, PATHOLOGY INTERNATIONAL, 71(7), 441-452, 202107
  51. Usefulness and safety of midline incision for right-sided hepatectomy: Cohort study, ANNALS OF MEDICINE AND SURGERY, 67, 202107
  52. An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan, TRANSPLANT INTERNATIONAL, 34(8), 1408-1421, 202108
  53. Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey, TRANSPLANTATION DIRECT, 7(8), 202108
  54. Laparoscopic resection of schwannoma in the hepatoduodenal ligament: a case report, SURGICAL CASE REPORTS, 7(1), 20210819
  55. The efficacy of rituximab treatment for antibody-mediated rejection in liver transplantation: A retrospective Japanese nationwide study, HEPATOLOGY RESEARCH, 51(9), 990-999, 202109
  56. B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4(+) T cell responses in highly sensitized transplant recipients, SCIENTIFIC REPORTS, 11(1), 20210913
  57. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance, GASTRIC CANCER, 24(6), 1264-1277, 202111
  58. Peritoneal lavage with hydrogen-rich saline can be an effective and practical procedure for acute peritonitis, SURGERY TODAY, 51(11), 1860-1871, 202111
  59. Molecular Mismatch Predicts T Cell-Mediated Rejection and De Novo Donor-Specific Antibody Formation After Living Donor Liver Transplantation, LIVER TRANSPLANTATION, 27(11), 1592-1602, 202111
  60. A multicenter randomized controlled trial comparing administration of antithrombin III after liver resection (HiSCO-05 trial), SURGERY, 170(4), 1140-1150, 202110
  61. Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab, MEDICINE, 100(42), 20211022
  62. Treatment of multiple huge liver cysts in a hybrid operating room: a case report, SURGICAL CASE REPORTS, 7(1), 20211029
  63. Outcomes of Pediatric Liver Transplantation in Japan: A Report from the Registry of the Japanese Liver Transplantation Society, TRANSPLANTATION, 105(12), 2587-2595, 202112
  64. Impacts of single nucleotide polymorphisms in Fc gamma receptor IIA (rs1801274) on lung transplant outcomes among Japanese lung transplant recipients, TRANSPLANT INTERNATIONAL, 34(11), 2192-2204, 202111
  65. Gradually progressive cholangiolocellular carcinoma: a case report, SURGICAL CASE REPORTS, 7(1), 20211220
  66. Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study, ANNALS OF GASTROENTEROLOGICAL SURGERY, 6(1), 149-158, 202201
  67. Distal Gastrectomy for Symptomatic Stage IV Gastric Cancer Contributes to Prognosis with Acceptable Safety Compared to Gastrojejunostomy, CANCERS, 14(2), 202201
  68. Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma, CANCER IMMUNOLOGY IMMUNOTHERAPY, 71(3), 589-599, 202203

Invited Lecture, Oral Presentation, Poster Presentation

  1. Evolving surgical approach in liver transplantation, Hideki Ohdan, MAKASSAR HEPATO-PANCREATICO-BILLIARY SURGERY FORUM, 2019/10/25, With Invitation, English, Indonesia
  2. Adoptive Transfer of Immune Reaction in LT, Hideki Ohdan, A-PHPBA 2019 ( the 7th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association), 2019/09/06, With Invitation, English, Korea
  3. Steroid resistant rejection:treatment and outcome, Hideki Ohdan, EML 2019 (Expert Meeting in Liver), 2019/04/27, With Invitation, Japanese
  4. Adaptive lmmunotherapy against HCC Recurrence after Transplantation, Hideki Ohdan, APASL STC 2019 Tokyo, 2019/04/20, With Invitation, Japanese
  5. Immunosuppressive therapy for liver transplantation: Strategies for personalization approaches, Hideki Ohdan, 2018/11/22, With Invitation, Japanese
  6. Impact of steatosis on the outcome of liver transplantation, Hideki Ohdan, ATW2018, 2018/11/09, With Invitation, English, ATW2018, Busan
  7. Strategies for personalizing immunosuppressive therapy in liver transplantation, Hideki Ohdan, The 3rd Myongji International Liver Symposium, 2018/09/07, With Invitation, Japanese, The 3rd Myongji International Liver Symposium, Hwajeong
  8. Immunosuppressive therapy in organ transplantation : Strategies for personalization approaches, Hideki Ohdan, 18th World Congress of Basic and Clinical Pharmacology, 2018/07/04, With Invitation, Japanese, Kyoto
  9. Liver resection without thermal damage of parenchyma by use of water-jet dissection, Hideki Ohdan, Tsuyoshi Kobayashi, 2018/06/08, Without Invitation, Japanese
  10. A novel immunotherapy to further improve the outcome of liver transplantation for hepatocellular carcinoma, Hideki Ohdan, Cairo University and Hiroshima University Annual Workshop, 2018/02/03, With Invitation, English, CAIRO UNIVERSITY, CAIRO
  11. Impact of Immunoregulatory gene polymorphism in ABO-incompatible liver transplantation, Hideki Ohdan, Asian Transplantation Week 2017, 2017/10/20, With Invitation, English, Asian Transplantation Week 2017, Incheon
  12. Practical ways to futher improve outcome of liver transplantation for HCC meeting Milan Criteria, Hideki Ohdan, the 53rd Annual Meeting of Liver Cancer Study Group of Japan, 2017/07/06, With Invitation, Japanese, the 53rd Annual Meeting of Liver Cancer Study Group of Japan
  13. Impact of donor-specific antibodies in liver transplantation, Hideki Ohdan, the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association(A-PHPBA2017) and the 29th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS29), 2017/06/10, With Invitation, Japanese, the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association(A-PHPBA2017) and the 29th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS29)
  14. A PHASED DESENSITIZATION WITH RITUXIMAB AND BORTEZOMIB FOR HIGHLY SENSITIZED KIDNEY TRANSPLANT CANDIDATES., Hideki Ohdan, Kentaro Ide, Yuka Tanaka., 15th Transplantation Science Symposium (TSS2017), 2017/05/24, Without Invitation, English, 15th Transplantation Science Symposium (TSS2017), Victoria, BC, Canada
  15. Don't change your winning Formula!, 2017/05/20, With Invitation, Japanese
  16. Adoptive Immunotherapy with Liver Allograft-Derived Lymphocytes Compensate for the Susceptibility to Post-LiverTransplant Blood Stream Infection Associated with FCGR3A SNP, Hideki Ohdan, 2017 American Transplant Congress, 2017/05/01, Without Invitation, English, American Transplant Congress, Chicago, Illinois
  17. Overexpression of KIFC1 is associated with gastric spheroid formation, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation, English
  18. Transmembrane protein BST2 is associated with poor survival in patients with gastric cancer, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation, English
  19. IQGAP3 is involved in spheroid formation of gastric cancer cells, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation, English
  20. Overexpression of PCDHB9 is associated with poor prognosis in gastric cancer, 2016/10, Without Invitation, English
  21. IQGAP3 is involved in spheroid formation of gastric cancer cells, Yuji Yamamoto, Naohide Oue, Takeharu Imai, Kazuaki Tanabe, Hideki Ohdan, Naoya Sakamoto, Kazuhiro Sentani, Kazuhiro Yoshida, Wataru Yasui, 第89回日本胃癌学会, 2017/03, Without Invitation, English
  22. The future perspective of conversion surgery for gastric cancer with liver metastasis, 89th Annual Meeting of The Japanese Gastric Cancer Association, 2017/03, Without Invitation, English
  23. Neo-adjuvant chemotherapy with G-SOX therapy for locally advanced gastric cancer., 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation, English
  24. Current status of desensitization protocol for highly HLA-sensitized kidney transplant candidates, Kentaro Ide Hiroyuki Tahara, Asuka Tanaka, Shuji Akimoto, Sapana Verma, Lalit Kumar Das, Seiichi Shimizu, Masahiro Ohira, Kohei Ishiyama, Yuka Tanaka, Hideki Ohdan, 第50回日本臨床腎移植学会, 2017/02, Without Invitation, English
  25. Corticosteroids dampen Natural Killer cell function including cytotoxicity and anti-HCV effect, Masahiro Ohira,Ryuichi Hotta, Takuya Yano, Ryosuke Nakano, Andreas Tzakis, Seigo Nishida, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation, English
  26. The Significant Association Between FOXP3 Gene Polymorphism and Severity of Acute Cellular Rejection in Liver Transplantation., Yuka Tanaka,Sapana Verma, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation, English
  27. Comparison of anti-donor immune response in recipients after kidney and pancreas-kidney transplantation, Kohei Ishiyama,Nobuki Ishida, Kentaro Ide, Yuka Tanaka, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation, English
  28. Players of clinical tolerance: Tregs, Bregs, Macrophages, and others, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation, English
  29. How to organize and support basic and translational research in transplantation, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation, English
  30. Japanese experience 1, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation, English
  31. Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: An exploratory study of the randomized phase II COMPASS tria, Tanabe K Yoshikawa T, Oshima Y, Miyagi S, Morita K, Nishikawa Y, Ito T, Matsui Y, Kimura T, Aoyama T, Hayashi T, Ogata H, Cho A, Tuburaya J, Sakamoto, ESMO 2016, 2016/10, Without Invitation, English
  32. Expression of Signal peptidase complex 18 is associated with poor survival of patients with esophageal cancer, yuji yamamoto Naohide Oue, Takeharu Imai, Naoya Sakamoto, Kazuhiro Sentani, Hideki Ohdan, Wataru Yasui, 2016/10, Without Invitation, English
  33. Toll-like receptor阻害剤を用いた新たな血液型抗原応答B細胞特異的制御法の基礎的解析, 2016/09, Without Invitation, Japanese
  34. 広島大学における急性肝不全症例に対する肝移植の検討, 2016/09, Without Invitation, Japanese
  35. 清水誠一 田中友加, 大平真裕, 石山宏平, 井手健太郎, 田原裕之, 佐伯吉弘, 坂井寛, 矢野琢也, 小林剛, 大段秀樹., 2016/09, Without Invitation, Japanese
  36. 臓器移植におけるATGの役割, 大段秀樹, 第52回日本移植学会総会, 2016/09, With Invitation, Japanese
  37. ABO血液型不適合移植における脱感作療法(腎移植・肝移植), 2016/09, With Invitation, Japanese
  38. 肝細胞癌に対する治癒切除症例の肝外再発予測因子, 本明慈彦 小林剛、橋本昌和、黒田慎太郎、石山宏平、井手健太郎、大平真裕、田原裕之、岩子寛、濱岡道則、沖本将、山口恵美、大段秀樹, 第110回広島がん治療研究会, 2016/09, Without Invitation, Japanese
  39. 同時性大腸癌腹膜播種症例における術前mGPSによる治療選択の検討, 田口和浩 安達智洋、惠木浩之、向井正一朗、矢野琢也、河内雅年、佐田春樹、寿美裕介、中島一記、田邊和昭、大段秀樹, 第110回広島がん治療研究会, 2016/09, Without Invitation, Japanese
  40. 局所進行直腸癌に対する術前化学放射線療法(CRT)の検討, 寿美裕介、惠木浩之、佐田春樹、安達智洋、向井正一郎、河内雅年、矢野琢也、田口和浩、中島一記、大段秀樹, 第91回中国四国外科学会総会, 2016/09, Without Invitation, Japanese
  41. 持続性ウイルス学的著効後に発症したC型肝炎関連肝細胞癌に対する肝切除後再発予測因子の検討, 沖本将、小林剛, 黒田慎太郎, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 清水誠一, 岩子寛, 濱岡道則, 本明慈彦, 山口恵美, 大段秀樹., 第91回中国四国外科学会総会, 2016/09, Without Invitation, Japanese
  42. 切除不能進行胃癌に対するConversion Surgeryの可能性 -胃癌肝転移に対する肝切除の適応基準の確立を目指して-, 堀田龍一、田邊和照, 鈴木崇久, 三隅俊博, 佐伯吉弘, 山本悠司, 竹原寛樹, 柳川泉一郎, 高橋元, 大段秀樹., 第91回中国四国外科学会総会, 2016/09, Without Invitation, Japanese
  43. von Willebrand病患者において安全に肝切除術を施行し得た1例, 2016/09, Without Invitation, Japanese
  44. 生体肝移植後にニューモシスチス・カリニ肺炎を発症しveno-venous Extra corporeal membrane oxygenation(vv-ECMO)にて救命し得た1例, 秋本修志 、田原裕之, 高橋元, 中島一記, 田口和浩, 田中飛鳥, 中野亮介, 石田伸樹, 柳川泉一郎, 矢野琢也, 坂井寛, 佐伯吉弘, 清水誠一, 大平真裕, 井手健太郎, 石山宏平, 黒田慎太郎, 小林剛, 大段秀樹., 2016/08, Without Invitation, Japanese
  45. Reduction in CXCL9–CXCR3 signals diminishes TRAIL-expressing liver NK cells in partially hepatectomized mice under depressed immune status., Yano T、Ohira M, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  46. Development of an anti-HLA antibody-producing humanized mouse model, Yanagawa S,Tahara H, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  47. Human endothelial-like cells transdifferentiated from monocytes suppress allo-reactive T cells, Tanaka Y,Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  48. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation., Tanaka A ,Morimoto H, IdeK, Tanaka Y, Ishiyama K, Ohira M, Tahara H, Shimizu S, Saeki Y, Sakai H, Tano T, Ishida N, Yanagawa S, Tagushi K, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  49. Clinical and immunological significance of controlling portal vein pressure in living donor liver transplantation, Taguchi K,Onoe T, Hashimoto S, Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  50. Various pathogenic microbes induce CNI-resistance in B-cells responding to blood group antigens through TLR-MyD88 pathway, Sakai H,Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  51. Long-lasting expansion of memory-like natural killer cells in the liver after intraportal syngeneic islet transplantation in mice, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  52. Negative influence of liver irradiation on liver resident NK cells., Nakano R,Ohira M, Yano T, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  53. Cotransplantation of preactivated mesenchymal stem cells inhibits liver natural killer cell–induced islet graft injury during instant blood-mediated inflammatory reaction after syngeneic intraportal islet transplantation, Ishida N,Ohdan H, Ishiyama K, Saeki Y, Tanaka Y, Tahara H, Verma S, Saparbay D, Sasaki Y, Onoe T, Ohira M, Yano T, Yanagawa S, Taguchi K, Piao J, Tanaka A, Ide K, Shimizu S, Das L K, Nakano R., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  54. Liver DX5- memory natural killer cells sustain cytotoxicity against intraportally transplanted islet, 2016/07, Without Invitation, Japanese
  55. Immunotherapy using donor liver NK cells for preventing severe infection after liver transplantation, 2016/07, Without Invitation, English
  56. Cross-Talk Between TLR and BCR Pathways Induces CNI-Resistance in B-Cells Responding to Blood Group A-Antigens: A Novel Paradigm for Treatment with TLR-Inhibitor for CNI-Resistant AMR., Sakai H,Tanaka Y, Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation, English
  57. Impact of Immunosuppressants on Inducing Regulatory T Cells in Human Allo-Immune Responses., Tanaka Y,Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation, English
  58. Significant association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation Phase., Das Lalit Kumar,K.Ide, Y.Tanaka, S.Shimizu, N.Tanimine, S.Verma, H.Ohdan, American Transplant Congress 2016, 2016/06, Without Invitation, English
  59. Significant association of Vitamin-D Receptor (VDR) Gene Polymorphism and Incidence od De Novo DSA in Renal Transplantation, Das Lalit Kumar,Ide K, Tanaka Y, Tanimine N, Verma S, Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation, English
  60. 細菌感染症により誘発される難治性抗体関連拒絶反応の新規メカニズムの解明, 坂井寛,田中友加, 山下正博, 佐々木由布, 中野亮介, 田口和浩, 石田伸樹, 柳川泉一郎, 矢野琢也, 佐伯吉弘, 清水誠一, 谷峰直樹, 大平真裕, 田原裕之, 井手健太郎, 石山宏平, 尾上隆司, 田代裕尊, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation, Japanese
  61. 肝細胞癌切除後の肝外再発予測因子, 橋本昌和,小林剛, 田代裕尊, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 黒田慎太郎, 岩子寛, 濱岡道則, 沖本将, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation, Japanese
  62. 大腸癌肝転移切除症例におけるGlasgow Prognostic Score の意義, 沖本将,小林剛, 田代裕尊, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 黒田慎太郎, 谷峰直樹, 岩子寛, 橋本昌和, 濱岡道則, 惠木浩之, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation, Japanese
  63. 80 歳以上の高齢者根治切除施行大腸がん手術症例におけるBMI による解析, 安達智洋,檜井孝夫, 川口康夫, 大段秀樹, 金澤旭宣, 中西正芳, 久保義郎, 伊藤雅昭, 猪俣雅史, 伴登宏行, 八岡利昌, 植木隆, 渡邊昌彦., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation, Japanese
  64. 肝移植術後重症感染症の起因菌推測と抗生剤選択における自然免疫遺伝子多型の意義, 清水誠一,田中友加, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 谷峰直樹, 佐伯吉弘, 坂井寛, 矢野琢也, 小林剛, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation, Japanese
  65. 消化器外科手術後における静脈血栓塞栓症の発症予測マーカーとしての可溶性フィブリンモノマー複合体(Soluble fibrin monomer complex,SFMC)の意義, 河内雅年,下村学, 檜井孝夫, 田邊和照, 惠木浩之, 石崎康代, 安達智洋, 田代裕尊, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation, Japanese
  66. 術中内視鏡を併用し根治切除しえた十二指腸腺腫・粘膜内癌の4例, 山本悠司,田邊和照, 堀田龍一, 佐伯吉弘, 竹原寛樹 大段秀樹., 第118回広島消化器病研究会, 2016/04, Without Invitation, Japanese
  67. Assessment using a novel predictive value and treatment for steroid-resistant acute cellular rejection after liver transplantation, Tahara H,Ishiyama K, Ide K, Tanaka Y, Ohira M, Tanimine N, Shimizu S, Kobayashi T, Ohdan H, Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation, English
  68. The phenotypic and functional distinction between B cells with receptors for human blood group A and B antigens, Sakai H,Tanaka Y, Masahiro Y, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation, English
  69. The Alcohol Use Disorder Identification Test-Consumption (AUDIT-C) predicts the risk of excessive alcohol consumption in patients after liver transplantation, Yano T, Ohira M, Sakamoto R, Narisada A, Tahara H, Ide K, Ishiyama K, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation, English
  70. The depletion of liver natural killer cells lead to successful engraftment of intraportal transplanted islet when insufficient number of islets used for islet transplantation, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation, English
  71. Distinct sensitivity of B-1a/B-1b/B-2 cell subpopulations to immunosuppressants, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation, English
  72. New approaches for ABO-mismatched solid organ transplantation., Hideki Ohdan, The 25th Regional Congress of the ISBT 2015, 2015/06/29, With Invitation, English, ISBT, LONDON
  73. Hepatocellular carcinoma patients who radiologically meet but pathologically exceed the Milan criteria are susceptible to recurrence after living-donor liver transplantation, Hideki Ohdan, 2015/06/11, With Invitation, English, tokyo
  74. Immunological feature of liver transplant recipients infected with HBV, 2014/11/20, Without Invitation, Japanese
  75. Controlling Anti-Carbohydrate Antibody Responses in Xenotransplantation, WTC2014, 2014/07/26, Without Invitation, English
  76. Impact of Fc-gamma receptor gene polymorphisms on susceptibility to infectious complication after liver transplantation, Japan Korea Transplantation Forum 2014, 2014/09/12, Without Invitation, English
  77. Adjuvant immunotherapy using liver NKCells enhances protective immunity against HCC recurrence and infectious complications in live rtransplantation., 2014/04/03, With Invitation, English

Awards

  1. 2010/10, CHUGAI Award, ドナー肝由来リンパ球を用いた肝移植後肝癌・C型肝炎再発予防免疫療法の臨床評価
  2. 2011/06/11, International TTS-JST Basic Science Mentee/Mentor Travel Award, XII The Transplantation Society Basic Science Symposium Chair Anita Chong, MD
  3. 2015/11/17, DP(Distinguished Professor), Hiroshima University
  4. 2015/12/07, Honorable Mention International Conference on Advanced Mechatronics (ICAM) 2015, ICAM2015 General Chair

Patented

  1. Patent, 5696317, 2015/02/20
  2. Patent, 5757483, 2015/06/12
  3. Patent, 6032669, 2016/11/04
  4. Patent, 6067330, 2017/01/06

External Funds

Acceptance Results of Competitive Funds

  1. Research Project for Practical Applications of Regenerative Medicine, 2021/04/01, 2022/03/31
  2. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation), 2021/04/01, 2022/03/31
  3. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation), 2021/04/01, 2022/03/31
  4. Research Program on Hepatitis, 2021/04/01, 2022/03/31
  5. Program on ICT Infrastructure Development for Clinical Research, 2017/04/01, 2018/03/31
  6. Research Program on Hepatitis , 2017/04/01, 2018/03/31
  7. Research Program on Hepatitis , 2017/04/01, 2018/03/31
  8. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2017/04/01, 2018/03/31
  9. Program on ICT Infrastructure Development for Clinical Research, 2016/10/17, 2017/03/31
  10. Research Program on Hepatitis , 2016/04/01, 2017/03/31
  11. Research Program on Hepatitis , 2016/04/01, 2017/03/31
  12. Research Program on Hepatitis , 2016/04/01, 2017/03/31
  13. Research Program on Hepatitis, 2015/04/01, 2016/03/31
  14. Research Program on Hepatitis, 2015/04/01, 2016/03/31
  15. Research Program on Hepatitis, 2015/04/01, 2016/03/31
  16. 2015/04/01, 2016/03/31
  17. KAKENHI, 2015, 2016
  18. KAKENHI, 2015, 2017
  19. KAKENHI, 2015, 2018
  20. 2015, 2015
  21. Health and Labour Sciences Research Grants, 2014/04/01, 2015/03/31
  22. 2014/03/01, 2017/03/31
  23. Health and Labour Sciences Research Grants, 2013/04/01, 2014/03/31
  24. KAKENHI, 2013, 2014
  25. KAKENHI, 2012, 2014
  26. 2011
  27. 2011
  28. 2011
  29. KAKENHI, Establishment of strategies to regulate antibody-mediated rejection on the basis of B cell differentiation biology, 2011, 2012
  30. KAKENHI, The CD47-SIRPa signaling blockade accelerates macrophage phagocytic activity against cancer cells, 2011, 2013
  31. 2010
  32. KAKENHI, The new strategy of NK cell therapy with death receptors for the patients with chollangiocellular carcinoma or mixed liver cancer, 2010, 2012
  33. 2009
  34. 2009
  35. KAKENHI, 2009, 2010
  36. KAKENHI, Inhibition of xeno-antigen reactive T cells and B cells by regulation of CD47-SIRP signaling, 2008, 2010
  37. KAKENHI, GalT-knockout pig to monkey xenogeneic kidney and islet transplantation, 2007, 2010
  38. KAKENHI, 2007, 2008
  39. KAKENHI, Regulation of innate and adaptive immune responses in xenotransplantation by modulating CD47sirp alpha signaling, 2006, 2007
  40. KAKENHI, Elucidation of the mechanism on carbohydrate antigen recognition by B cells through CD1d mediated signaling and establishment of a method to regulate B cells responding to the carbohydrate antigens in ABO-incompatible transplantation and xe, 2006, 2007
  41. KAKENHI, 2006, 2007
  42. KAKENHI, 2005, 2006
  43. KAKENHI, 2005, 2006
  44. KAKENHI, 2005, 2006
  45. KAKENHI, Elucidation of mechanisms for macrophage-mediated xenograft refection and a novel approach to prevent macrophage-mediated xenograft rejection by gene introduction of human CD47 to xenogenic cells, 2004, 2005
  46. KAKENHI, Development of synthetic immunotoxin that can enable ABC incompatible transplantation and xenotransplantation., 2004, 2005
  47. ICT infrastructure establishment and implementation of artificial intelligence for clinical and medical research , 2018/04/01, 2019/03/31
  48. Research Program on Hepatitis , 2018/04/01, 2019/03/31
  49. Research Program on Hepatitis , 2018/04/01, 2019/03/31
  50. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2018/04/01, 2019/03/31
  51. KAKENHI(Grant-in-Aid for Challenging Research (Pioneering)), 2018, 2020
  52. Research Program on Hepatitis , 2019/04/01, 2020/03/31
  53. Research Program on Hepatitis , 2019/04/01, 2020/03/31
  54. Research Project for Practical Applications of Regenerative Medicine , 2019/04/01, 2020/03/31
  55. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2019/04/01, 2020/03/31
  56. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2019/04/01, 2020/03/31
  57. KAKENHI(Grant-in-Aid for Scientific Research (A)), 2019, 2021
  58. Research Program on Hepatitis, 2020/04/01, 2021/03/31
  59. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation), 2020/04/01, 2021/03/31
  60. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation), 2020/05/12, 2021/03/31
  61. Research Project for Practical Applications of Regenerative Medicine, 2020/04/01, 2021/03/31

Social Activities

Organizing Academic Conferences, etc.

  1. 2011/12
  2. 2012/05
  3. 2013/08
  4. 2014/06, 2014/06
  5. 2014/09, 2014/09
  6. 2015/03, 2015/03
  7. 2015/09, 2015/09
  8. 2016/03, 2016/03
  9. 89th Annual Meeting of the Japanese Gastric Cancer Association, 2016/03, 2016/03
  10. 2016/09, 2016/09
  11. 2016/09, 2016/09
  12. 2017/06, 2017/06
  13. 2017/09, 2017/09

History as Peer Reviews of Academic Papers

  1. 2010, Surgery Today, Editor
  2. 2011, Surgery Today, Editor
  3. 2012, Surgery Today, Editor
  4. 2012, Hepatology Research, Others
  5. 2013, Surgery Today, Editor
  6. 2013, Hepatology Research, Others
  7. 2014, Surgery Today, Editor
  8. 2014, Hepatology Research, Others
  9. 2014, Transplant International, Editor, Associate Editor, 24
  10. 2014, Surgical case reports, Editor, Associate Editor, 24
  11. 2015, Hepatrology Research, Editor, associate editor
  12. 2015, Surgical case reports, Editor, associate editor
  13. 2015, Transplant International, Editor, associate editor
  14. 2016, Hiroshima Journal of Medical Science, Editor, 0
  15. 2016, Transplant International, Editor, associate editor
  16. 2016, Surgical case reports, Editor, associate editor
  17. 2016, Hepatology Research, Editor, associate editor
  18. 2017, Hepatology Research, Editor, Associate Editor